These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 33000310)

  • 21. Immunogenicity of bacteriophage lambda particles displaying porcine Circovirus 2 (PCV2) capsid protein epitopes.
    Gamage LN; Ellis J; Hayes S
    Vaccine; 2009 Nov; 27(47):6595-604. PubMed ID: 19712770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure-Based Design of Porcine Circovirus Type 2 Chimeric VLPs (cVLPs) Displays Foreign Peptides on the Capsid Surface.
    Wang D; Zhang S; Zou Y; Yu W; Jiang Y; Zhan Y; Wang N; Dong Y; Yang Y
    Front Cell Infect Microbiol; 2018; 8():232. PubMed ID: 30038901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficient production of porcine circovirus virus-like particles using the nonconventional yeast Kluyveromyces marxianus.
    Duan J; Yang D; Chen L; Yu Y; Zhou J; Lu H
    Appl Microbiol Biotechnol; 2019 Jan; 103(2):833-842. PubMed ID: 30421111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incorporation of a truncated form of flagellin (TFlg) into porcine circovirus type 2 virus-like particles enhances immune responses in mice.
    Liu X; Liu Y; Zhang Y; Zhang F; Du E
    BMC Vet Res; 2020 Feb; 16(1):45. PubMed ID: 32028949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficient application of a baculovirus-silkworm larvae expression system for obtaining porcine circovirus type 2 virus-like particles for a vaccine.
    He Q; Cao Z; Wang P; Lu Q; Zheng H; Sun J
    Arch Virol; 2020 Oct; 165(10):2301-2309. PubMed ID: 32757056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficient production of type 2 porcine circovirus-like particles by a recombinant baculovirus.
    Liu LJ; Suzuki T; Tsunemitsu H; Kataoka M; Ngata N; Takeda N; Wakita T; Miyamura T; Li TC
    Arch Virol; 2008; 153(12):2291-5. PubMed ID: 18998045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of recombinant porcine parvovirus-like particles as an antigen carrier formed by the hybrid VP2 protein carrying immunoreactive epitope of porcine circovirus type 2.
    Pan Q; He K; Huang K
    Vaccine; 2008 Apr; 26(17):2119-26. PubMed ID: 18378364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neutralization Mechanism of a Monoclonal Antibody Targeting a Porcine Circovirus Type 2 Cap Protein Conformational Epitope.
    Huang L; Sun Z; Xia D; Wei Y; Sun E; Liu C; Zhu H; Bian H; Wu H; Feng L; Wang J; Liu C
    J Virol; 2020 Apr; 94(9):. PubMed ID: 32075932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protection of pigs against post-weaning multisystemic wasting syndrome by a recombinant adenovirus expressing the capsid protein of porcine circovirus type 2.
    Wang X; Jiang P; Li Y; Jiang W; Dong X
    Vet Microbiol; 2007 Apr; 121(3-4):215-24. PubMed ID: 17215092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protective immunity conferred by porcine circovirus 2 ORF2-based DNA vaccine in mice.
    Sylla S; Cong YL; Sun YX; Yang GL; Ding XM; Yang ZQ; Zhou YL; Yang M; Wang CF; Ding Z
    Microbiol Immunol; 2014 Jul; 58(7):398-408. PubMed ID: 24845706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Heterologous Viral Protein Scaffold for Chimeric Antigen Design: An Example PCV2 Virus Vaccine Candidate.
    Lamazares E; Gutiérrez F; Hidalgo A; Gutiérrez NA; Espinoza FI; Sánchez O; Cortez-San Martín M; Mascayano C; González J; Saavedra J; Altamirano C; Mansur M; Ruiz Á; Toledo JR
    Viruses; 2020 Mar; 12(4):. PubMed ID: 32244384
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of antigenic epitopes of porcine reproductive and respiratory syndrome virus (PRRSV) in a modified live-attenuated porcine circovirus type 2 (PCV2) vaccine virus (PCV1-2a) as a potential bivalent vaccine against both PCV2 and PRRSV.
    Piñeyro PE; Kenney SP; Giménez-Lirola LG; Heffron CL; Matzinger SR; Opriessnig T; Meng XJ
    Virus Res; 2015 Dec; 210():154-64. PubMed ID: 26239318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generation of E. coli-derived virus-like particles of porcine circovirus type 2 and their use in an indirect IgG enzyme-linked immunosorbent assay.
    Zhang Y; Wang Z; Zhan Y; Gong Q; Yu W; Deng Z; Wang A; Yang Y; Wang N
    Arch Virol; 2016 Jun; 161(6):1485-91. PubMed ID: 26973229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-level expression and immunogenicity of porcine circovirus type 2b capsid protein without nuclear localization signal expressed in Hansenula polymorpha.
    Xiao Y; Zhao P; Du J; Li X; Lu W; Hao X; Dong B; Yu Y; Wang L
    Biologicals; 2018 Jan; 51():18-24. PubMed ID: 29225046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protective humoral immunity in guinea pigs induced by PCV2 virus-like particles displaying the B cell linear epitope (
    Wang N; Zhang S; Wang D; Li F; Liang L; Li X; Zou Y; Zhan Y; Chen G; Yu W; Deng Z; Tu D; Cui S
    Vet Microbiol; 2019 Aug; 235():86-92. PubMed ID: 31282383
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incorporation of ORF2 from Porcine Circovirus Type 2(PCV2) into genetically encoded nanoparticles as a novel vaccine using a self-aggregating peptide.
    Zepeda-Cervantes J; Cruz-Reséndiz A; Sampieri A; Carreón-Nápoles R; Sánchez-Betancourt JI; Vaca L
    Vaccine; 2019 Mar; 37(14):1928-1937. PubMed ID: 30824359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibody responses following vaccination versus infection in a porcine circovirus-type 2 (PCV2) disease model show distinct differences in virus neutralization and epitope recognition.
    Trible BR; Ramirez A; Suddith A; Fuller A; Kerrigan M; Hesse R; Nietfeld J; Guo B; Thacker E; Rowland RR
    Vaccine; 2012 Jun; 30(27):4079-85. PubMed ID: 22521847
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amino acid mutations in the capsid protein produce novel porcine circovirus type 2 neutralizing epitopes.
    Liu J; Huang L; Wei Y; Tang Q; Liu D; Wang Y; Li S; Guo L; Wu H; Liu C
    Vet Microbiol; 2013 Aug; 165(3-4):260-7. PubMed ID: 23582511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The level of decoy epitope in PCV2 vaccine affects the neutralizing activity of sera in the immunized animals.
    Jin J; Park C; Cho SH; Chung J
    Biochem Biophys Res Commun; 2018 Feb; 496(3):846-851. PubMed ID: 29374509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the use of non-pathogenic porcine circovirus type 1 as a vaccine delivery virus vector to express antigenic epitopes of porcine reproductive and respiratory syndrome virus.
    Piñeyro PE; Kenney SP; Giménez-Lirola LG; Opriessnig T; Tian D; Heffron CL; Meng XJ
    Virus Res; 2016 Feb; 213():100-108. PubMed ID: 26555162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.